Martin F. Haslanger
Directeur/Membre du Conseil chez Apexian Pharmaceuticals, Inc.
Profil
Martin F.
Haslanger is the founder of Amphora Discovery Corp.
founded in 2001 where he held the title of Vice Chairman.
He is currently a Director at Apexian Pharmaceuticals, Inc. Dr. Haslanger's former jobs include Executive Director-Research Technologies at Eli Lilly & Co. from 1992 to 2001, Director-Cardiovascular & CNS Medicinal Chemistry at Schering-Plough Research Institute, and Group Leader at Squibb Institute for Medical Research.
Dr. Haslanger received a doctorate degree from the University of Michigan.
Postes actifs de Martin F. Haslanger
| Sociétés | Poste | Début |
|---|---|---|
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin F. Haslanger
| Sociétés | Poste | Fin |
|---|---|---|
Amphora Discovery Corp.
 Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Fondateur | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Squibb Institute for Medical Research | Corporate Officer/Principal | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formation de Martin F. Haslanger
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 4 |
|---|---|
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Amphora Discovery Corp. develops and manufactures pharmaceutical products. It provides custom assay development and enzymology services. The company provides drug discovery contract research services, HTS, profiling and lead generation services. The company was founded in September 2001 and is headquartered in Durham, NC. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
| Squibb Institute for Medical Research |
